• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用PUGNAc和胰岛素样生长因子-1处理后,Akt1会被O-连接的N-乙酰葡糖胺动态修饰。

Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.

作者信息

Gandy Johanna C, Rountree Abigail E, Bijur Gautam N

机构信息

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Sparks Center, Room 1009, Birmingham, AL 35294-0017, USA.

出版信息

FEBS Lett. 2006 May 29;580(13):3051-8. doi: 10.1016/j.febslet.2006.04.051. Epub 2006 Apr 27.

DOI:10.1016/j.febslet.2006.04.051
PMID:16684529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2493066/
Abstract

The Ser/Thr kinase Akt1 is activated by growth factors subsequent to its phosphorylation on Thr308 and Ser473. In the present study, Akt1 was found to be constitutively modified with O-GlcNAc. Treatment of SH-SY5Y cells with O(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), which inhibits the enzymatic removal of O-GlcNAc from proteins, increased cytosolic O-GlcNAc-Akt1 levels. Treatment of cells with insulin-like growth factor-1 (IGF-1) also increased O-GlcNAc-Akt1 levels and increased Akt1 phosphorylation. PUGNAc treatment did not attenuate IGF-1 induced Akt1 phosphorylation. These results indicate that Akt1 can be simultaneously modified with O-GlcNAc and phosphorylated. However, PUGNAc induced the nuclear accumulation of Akt1 suggesting that the O-GlcNAc-modification on Akt1 may play a role in Akt1 nuclear localization.

摘要

丝氨酸/苏氨酸激酶Akt1在苏氨酸308和丝氨酸473磷酸化后被生长因子激活。在本研究中,发现Akt1持续被O-连接的N-乙酰葡糖胺(O-GlcNAc)修饰。用O(2-乙酰氨基-2-脱氧-D-吡喃葡萄糖亚基)氨基-N-苯基氨基甲酸酯(PUGNAc)处理SH-SY5Y细胞,该物质可抑制从蛋白质上去除O-GlcNAc的酶促反应,从而增加了胞质中O-GlcNAc-Akt1的水平。用胰岛素样生长因子-1(IGF-1)处理细胞也增加了O-GlcNAc-Akt1的水平并增加了Akt1的磷酸化。PUGNAc处理并未减弱IGF-1诱导的Akt1磷酸化。这些结果表明Akt1可同时被O-GlcNAc修饰并磷酸化。然而,PUGNAc诱导了Akt1的核内积累,提示Akt1上的O-GlcNAc修饰可能在Akt1的核定位中起作用。

相似文献

1
Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.在用PUGNAc和胰岛素样生长因子-1处理后,Akt1会被O-连接的N-乙酰葡糖胺动态修饰。
FEBS Lett. 2006 May 29;580(13):3051-8. doi: 10.1016/j.febslet.2006.04.051. Epub 2006 Apr 27.
2
O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.PUGNAc对胰岛素受体底物-1(IRS-1)和蛋白激酶B2(Akt2)的O-连接N-乙酰葡糖胺修饰抑制了它们的磷酸化,并在大鼠原代脂肪细胞中诱导胰岛素抵抗。
Exp Mol Med. 2005 Jun 30;37(3):220-9. doi: 10.1038/emm.2005.30.
3
Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.使用肽 O-连接的 N-乙酰葡糖胺-β-N-乙酰葡糖胺酶抑制剂 O-(2-乙酰氨基-2-脱氧-D-吡喃葡糖亚基)氨基-N-苯基氨基甲酸酯在体内调节核蛋白和细胞质蛋白上的 O-连接 N-乙酰葡糖胺水平。
J Biol Chem. 1998 Feb 6;273(6):3611-7. doi: 10.1074/jbc.273.6.3611.
4
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.O-连接的N-乙酰葡糖胺(O-GlcNAc)导致的核质糖基化升高会引发3T3-L1脂肪细胞中与Akt激活缺陷相关的胰岛素抵抗。
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5313-8. doi: 10.1073/pnas.072072399.
5
Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.在PUGNAc中长时间孵育会导致大鼠骨骼肌中蛋白质O-连接糖基化增加和胰岛素抵抗。
Diabetes. 2004 Apr;53(4):921-30. doi: 10.2337/diabetes.53.4.921.
6
Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.通过分析 ATP 结合蛋白组,用 PUGNAc 处理 3T3-L1 脂肪细胞鉴定差异表达蛋白。
Proteomics. 2013 Oct;13(20):2998-3012. doi: 10.1002/pmic.201200549.
7
E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.大肠杆菌破坏体内 O-连接β-N-乙酰葡萄糖胺修饰蛋白的产生。
J Biotechnol. 2013 Dec;168(4):315-23. doi: 10.1016/j.jbiotec.2013.10.008. Epub 2013 Oct 16.
8
PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.PUGNAc 处理导致 CHO 细胞中游离寡糖的异常积累。
J Biochem. 2012 Apr;151(4):439-46. doi: 10.1093/jb/mvs012. Epub 2012 Feb 15.
9
Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.氨基葡萄糖诱导的Akt磷酸化增加与星形胶质细胞内质网应激增加相对应。
Mol Cell Biochem. 2007 Apr;298(1-2):109-23. doi: 10.1007/s11010-006-9358-5. Epub 2006 Nov 30.
10
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.蛋白质O-连接的N-乙酰葡糖胺修饰增加可抑制对急性腔内动脉损伤的炎症和新生内膜反应。
Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H335-42. doi: 10.1152/ajpheart.01259.2007. Epub 2008 May 9.

引用本文的文献

1
Protein O-GlcNAcylation in reproductive biology and the impact of metabolic disease.生殖生物学中的蛋白质O-连接N-乙酰葡糖胺化修饰以及代谢性疾病的影响
Hum Reprod Update. 2025 Jun 26. doi: 10.1093/humupd/dmaf013.
2
-GlcNAcylation and Phosphorylation Crosstalk in Vascular Smooth Muscle Cells: Cellular and Therapeutic Significance in Cardiac and Vascular Pathologies.血管平滑肌细胞中的O-连接N-乙酰葡糖胺化与磷酸化相互作用:在心脏和血管疾病中的细胞及治疗意义
Int J Mol Sci. 2025 Apr 2;26(7):3303. doi: 10.3390/ijms26073303.
3
O-GlcNAcylation in Endocrinology: The Sweet Link.内分泌学中的O-连接N-乙酰葡糖胺化修饰:甜蜜的联系
Endocrinology. 2025 Apr 22;166(6). doi: 10.1210/endocr/bqaf072.
4
The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation.CTCF 的 PTM 谱分析揭示了 O-GlcNAcylation 对 3D 染色质结构的调节作用。
Nat Commun. 2024 Apr 1;15(1):2813. doi: 10.1038/s41467-024-47048-3.
5
The O-GlcNAc dichotomy: when does adaptation become pathological?O-GlcNAc 二分法:何时适应变为病理性?
Clin Sci (Lond). 2023 Nov 29;137(22):1683-1697. doi: 10.1042/CS20220309.
6
O-GlcNAcylation Inhibits Endocytosis of Amyloid Precursor Protein by Decreasing Its Localization in Lipid Raft Microdomains.O-连接的N-乙酰葡糖胺化通过减少淀粉样前体蛋白在脂筏微结构域中的定位来抑制其胞吞作用。
Membranes (Basel). 2021 Nov 23;11(12):909. doi: 10.3390/membranes11120909.
7
Role of -Linked -Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.-O-连接的乙酰葡萄糖胺蛋白修饰在细胞(病理)生理学中的作用。
Physiol Rev. 2021 Apr 1;101(2):427-493. doi: 10.1152/physrev.00043.2019. Epub 2020 Jul 30.
8
The O-GlcNAc Modification on Kinases.激酶上的 O-GlcNAc 修饰。
ACS Chem Biol. 2020 Mar 20;15(3):602-617. doi: 10.1021/acschembio.9b01015. Epub 2020 Mar 10.
9
Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).对细胞内糖基化(O-GlcNAc)功能的关键性观察,塑造了我们对此的理解。
FEBS Lett. 2018 Dec;592(23):3950-3975. doi: 10.1002/1873-3468.13286. Epub 2018 Nov 24.
10
Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.营养驱动的O-连接N-乙酰葡糖胺在蛋白质稳态和神经退行性变中的作用
J Neurochem. 2018 Jan;144(1):7-34. doi: 10.1111/jnc.14242. Epub 2017 Nov 20.

本文引用的文献

1
O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.O-连接的N-乙酰葡糖胺循环:一种单一的糖基化修饰如何改变我们对信号网络的认知方式。
J Cell Biochem. 2006 Jan 1;97(1):71-83. doi: 10.1002/jcb.20676.
2
O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.PUGNAc对胰岛素受体底物-1(IRS-1)和蛋白激酶B2(Akt2)的O-连接N-乙酰葡糖胺修饰抑制了它们的磷酸化,并在大鼠原代脂肪细胞中诱导胰岛素抵抗。
Exp Mol Med. 2005 Jun 30;37(3):220-9. doi: 10.1038/emm.2005.30.
3
O-GlcNAc glycosylation: a signal for the nuclear transport of cytosolic proteins?O-连接的N-乙酰葡糖胺糖基化:一种胞质蛋白核转运的信号?
Int J Biochem Cell Biol. 2005 Apr;37(4):765-74. doi: 10.1016/j.biocel.2004.12.001.
4
Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.在PUGNAc中长时间孵育会导致大鼠骨骼肌中蛋白质O-连接糖基化增加和胰岛素抵抗。
Diabetes. 2004 Apr;53(4):921-30. doi: 10.2337/diabetes.53.4.921.
5
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.磷脂酰肌醇3激酶激活后,Akt迅速在线粒体中积累。
J Neurochem. 2003 Dec;87(6):1427-35. doi: 10.1046/j.1471-4159.2003.02113.x.
6
Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.用于分析核质蛋白糖基化和磷酸化之间动态关系的蛋白质组学方法。
Circ Res. 2003 Nov 28;93(11):1047-58. doi: 10.1161/01.RES.0000103190.20260.37.
7
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.O-连接的N-乙酰葡糖胺(O-GlcNAc)导致的核质糖基化升高会引发3T3-L1脂肪细胞中与Akt激活缺陷相关的胰岛素抵抗。
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5313-8. doi: 10.1073/pnas.072072399.
8
Ten years of protein kinase B signalling: a hard Akt to follow.蛋白激酶B信号传导的十年:难以追踪的Akt
Trends Biochem Sci. 2001 Nov;26(11):657-64. doi: 10.1016/s0968-0004(01)01958-2.
9
Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis.细胞质O-糖基化在细胞凋亡过程中阻止E-钙黏蛋白向细胞表面转运。
EMBO J. 2001 Nov 1;20(21):5999-6007. doi: 10.1093/emboj/20.21.5999.
10
PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?蛋白激酶B/蛋白激酶Akt:细胞增殖、存活及胰岛素反应的关键调节因子?
J Cell Sci. 2001 Aug;114(Pt 16):2903-10. doi: 10.1242/jcs.114.16.2903.